Ann: Business Update, page-4

" Through academic, commercial and investment contacts, board members and executives have had a
range of confidential discussions about potential new projects and partnerships. The company is not
in a position to disclose any further details at present.

The company is also pursuing options to identify a viable next step in the development of NTCELL®
for Parkinson’s disease.

Otsuka Pharmaceutical Factory continues to invest in its DIABECELL® programme."

So yes, non specific, but they are saying they haven't entirely gone into hibernation.
But clearly they will either need to be in a partnership or raise capital to do anything worthwhile, unless Otsuka do finally get something in the works for Diabecell.